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Abstract 
Purpose: The present study examined the associations between internalizing disorders and 
substance use disorders using structural equation models to examine the relative contributions of 
common fixed confounding factors and direct causal pathways, and to determine the direction of 
causality. 
Methods: Data were gathered during the course of the Christchurch Health and Development 
Study, a 25-year longitudinal study of a birth cohort of New Zealand children (n = 953).  Measures 
included DSM-IV symptom criteria for major depression, anxiety disorders, alcohol 
abuse/dependence, nicotine dependence, and illicit drug abuse/dependence, ages 18, 21, and 25. 
Results: Structural equation modelling showed that for depression and substance use disorder, the 
best-fitting model was one in which the associations were explained by a combination of common 
fixed factors and direct causal pathways from substance use to depression.  A similar pattern 
emerged for anxiety disorders and: a) nicotine dependence; and b) illicit drug abuse/dependence.  
The comorbidity of anxiety disorder and alcohol abuse/dependence was best explained by a model 
that included common fixed factors and a reciprocal pathway between these disorders.  
Decomposition of the correlations between internalizing disorders and substance use disorders 
showed that most of the correlation arose from direct causal pathways between disorders. 
Conclusions: The findings suggest that the comorbidity between internalizing disorders and 
substance use disorders can be attributed to both common fixed factors and direct causal pathways 
between substance use disorder and internalizing disorder.  The evidence suggests that, in most 
cases, the most plausible explanation of causality is one in which substance use disorder increases 
the risk of internalizing disorder. 
 
Keywords: internalizing disorders; substance use disorders; longitudinal study; structural equation 
models 
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The comorbidities between substance (alcohol, nicotine and illicit drug) use disorders and 
internalizing disorders, including major depression and anxiety disorders, have been well 
documented [1-5]. In general, research suggests that those reporting substance use disorders are at 
an increased risk of major depression and anxiety disorders [6-9], and those reporting internalizing 
disorders are at an increased risk of  alcohol abuse/dependence, nicotine dependence, and  illicit 
drug abuse/dependence [10-13].  In turn, these pervasive comorbidities between substance use and 
internalizing disorders have raised important questions about the underlying processes that lead to 
such comorbidity [5-34]. 
Leaving aside explanations that attribute these associations to methodological artefact, there 
are potentially four explanations of the underlying causal processes that lead to the comorbidity of 
substance use disorders and internalizing disorders [14, 34].  First, it may be suggested that these 
comorbidities arises from common or correlated factors that predispose the individual to both 
substance use disorders and internalizing disorders. These factors may include both genetic and 
environmental factors shared by internalizing and substance use disorders.  Second, it may be 
proposed that the associations arise as a result of self-medication processes which predispose those 
with internalizing disorders to use substances in order to mitigate symptoms of depression or 
anxiety. Third, it may be suggested that the associations arise because of social and/or biological 
processes that result in the use of substances increasing risks of major depression and anxiety 
disorders. Finally it may be suggested that the associations arise from a reciprocal feedback loop 
involving simultaneous causation between substance use disorders and internalizing disorders.  
To date, the evidence on which of these models provides the best explanation of the 
comorbidity of substance use disorders and internalizing disorders has not been fully conclusive. 
While the majority of studies in this area have concluded that the comorbidities between substance 
use and internalizing disorders cannot be explained entirely by common risk factors, there has been 
less agreement about the direction of any remaining causal associations [8-26, 34-36].  For 
example, a number of studies have suggested that substance use may arise as a result of self-
 4 
medication of symptoms of internalizing disorder [10-13, 15, 17-21, 26, 35, 36], whereas other 
studies have suggested have found evidence that substance use increases the risks of internalizing 
disorder [8, 9, 16, 20, 22-25, 28, 31, 32].    
In this paper we use data from a 25-year longitudinal study of a New Zealand birth cohort to 
develop a systematic structural equation modelling approach for exploring the underlying causal 
structures that may explain the comorbidities of substance use disorders and internalizing disorders. 
This model is an extension of previously published work into the comorbidities of major depression 
and alcohol use, and major depression and cigarette smoking [14, 34]. In this study we extend these 
analyses to examine the linkages between a series of substance use disorders (alcohol 
abuse/dependence; nicotine dependence; illicit drug abuse/dependence) and major depression and 
anxiety disorders. 
The logic of the analysis is shown in the path diagram in Figure 1.  The model seeks to 
explain the comorbidities (correlations) between a specific measure of internalizing disorder (I) and 
a specific substance use disorder (S) observed at three time periods.  The model assumes that: 
1) The observed symptom measures of internalizing disorder (denoted It; t = 1, 2, 3) are influenced 
by fixed sources of variation (I) that are constant over time, and by time-dynamic sources of 
variation (Ut), while the observed symptom measures of substance use disorder (denoted St; t = 
1, 2, 3) are influenced by fixed sources of variation (S) that were constant over time, and by 
time-dynamic sources of variation (Wt).  The fixed factors I and S are permitted to be 
correlated; 
2) The time-dynamic components of internalizing symptoms and substance use disorder symptoms 
are linked by autoregressive processes in which past symptoms predicted future symptoms; 
3) The time-dynamic components of internalizing and substance use disorder symptoms are 
reciprocally related at t = 2 or 3 so that current Ut influenced current Wt, and vice-versa, with 
these reciprocal effects assumed to be constant over time. 
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In general, the model contains parameters that represent the effects of the common correlated 
factors I and S on the correlation between Xt and Yt, and direct causal pathways between substance 
use disorder and internalizing disorder.  The model is described in greater details in Methods. 
 
INSERT FIGURE 1 HERE 
 
In the following analysis, we fit the model in Figure 1 to examine the comorbidities between 
internalizing disorders (depression; anxiety) and substance use disorders (alcohol 
abuse/dependence; nicotine dependence; illicit drug abuse/dependence).  The aim of this analysis is 
to explore the extent to which the comorbidities between substance use disorders and internalizing 





The data were gathered during the course of the Christchurch Health and Development Study 
(CHDS). In this study an unselected birth cohort of 1265 children (635 males, 630 females) born in 
the Christchurch (New Zealand) urban region in mid-1977 has been studied at birth, 4 months, 1 
year and annually to age 16 years, and again at ages 18, 21 and 25 years.  Data have been gathered 
from a combination of sources including: parental interviews; self-reports; psychometric tests; 
teacher reports; medical and other official records.  A detailed description of the CHDS and an 
overview of study findings on a wide variety of topics can be found in Fergusson, Horwood, 
Shannon, and Lawton [37] and Fergusson and Horwood [38].  All study information was collected 
on the basis of signed consent from study participants, and the study received ethical approval from 
the Canterbury Ethics Committee. 
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Internalizing disorders and substance use disorders, ages 18, 21, and 25 
At ages 18, 21, and 25 years, study participants were interviewed on a structured mental health 
interview designed to assess DSM-IV [39] diagnostic criteria for a range of disorders including 
major depression, anxiety disorders (GAD, panic disorder, agoraphobia, social phobia, specific 
phobia), alcohol abuse/dependence, nicotine dependence and illicit drug abuse/dependence. 
Symptom criteria for nicotine dependence were assessed using custom written survey items [40], 
and for all other disorders assessments were based on the relevant components of the Composite 
International Diagnostic Interview (CIDI) [41].  
For the purposes of the structural equation modeling these data were used to classify 
participants on 3 level ordinal measures reflecting the severity of internalizing disorder or substance 
use disorder symptomatology. For each disorder this scale was: 0 = had no symptoms of disorder; 1 
= had symptoms of disorder but did not meet DSM diagnostic criteria for disorder; 2 = met DSM 
diagnostic criteria for disorder. For the measures of depression and substance use disorders, this 
classification was based on meeting diagnostic criteria in the 12 months prior to the assessment. 
However, since the 12 month prevalence of anxiety disorder symptomatology was not assessed at 
all ages, the classification for anxiety disorder was based upon participant reports of meeting 
diagnostic criteria for any anxiety disorder in the period since the previous assessment.  
 In addition, for the purposes of examining the robustness of the data to alternative methods 
of measurement using structural equation modelling, the dichotomous responses (yes; no) to each 
individual symptom item in the symptom reports were summed at ages 18, 21, and 25 to create a 
measure of the total number of symptoms of internalizing or substance use disorder reported during 
the year prior to each assessment.  The sole exception to this was anxiety disorder, as the nature of 
the symptom criteria for these disorders differs substantially from the other disorders examined in 
the present study [39].  For these particular analyses only, a measure of the total number of 
individual anxiety disorders reported at each assessment (ranging from 0-3) served as the measure 




To explore issues of associations and causal direction between the measures of internalizing 
disorder and each measure of substance use disorder, a series of structural equation models was 
fitted to the categorical measures of internalizing disorders and substance use disorders observed for 
the three intervals 17-18, 20-21 and 24-25 years. These models incorporated fixed effects 
influencing the measures of internalizing disorder and substance use disorder over time; and also 
incorporated causal pathways that had the potential to examine both unidirectional and reciprocal 
effects between internalizing disorders and substance use disorders within time intervals.  The 
modelling procedure was conducted such that major depression was paired with alcohol 
abuse/dependence; nicotine dependence; and illicit drug abuse/dependence.  Then, anxiety disorder 
was paired with alcohol abuse/dependence; nicotine dependence; and illicit drug abuse/dependence.  
In total, six series of structural equation models were fitted. 
Figure 1 (above) depicts a model with fixed effects influencing both internalizing disorder 
and substance use disorder, and includes paths representing reciprocal causal effects between 
internalizing disorder and substance use disorder. This model assumed: (a) the observed symptom 
measures of internalizing (denoted It, t = 1, 2, 3) at ages 17-18 (t =1 ), 20-21 (t = 2) and 24-25 (t = 
3) were influenced by fixed sources of variation (I) that were constant over time and by time-
dynamic sources of variation (Ut); (b) the observed symptom measures of substance use disorder 
(denoted St, t =1, 2, 3) were also influenced by fixed sources of variation (S) that were constant 
over time and by time-dynamic sources of variation (Wt); (c) the fixed factors I and S were 
permitted to be correlated; (d) the time-dynamic components of depressive symptoms (Ut) and 
substance use disorder symptoms (Wt) were linked by autoregressive processes in which past 
internalizing disorder symptoms predicted future internalizing disorder symptoms, and past 
substance use disorder symptoms predicted future substance use disorder symptoms respectively; 
(e) that the time-dynamic components of internalizing disorder and substance use disorder were 
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reciprocally related at t = 2, 3 so that current Ut influenced current Wt and vice versa. These 
reciprocal effects were assumed to be constant over time; and  (f) the time-dynamic components U1 
and W1 were assumed to be correlated rather than reciprocally related in order to assist with model 
identifiability.  
In this model the fixed effects (I, S) are latent variables that summarize the net effect of all 
non-observed fixed factors that exert a constant effect on the measures of internalizing disorder and 
substance use disorder respectively over time. These factors include all childhood, family and 
personal characteristics that have a fixed effect on outcomes over time, and thus may include both 
genetic and environmental influences. The time-dynamic components of the model (Ut, Wt) 
represent the effect of all other sources of variance in internalizing disorder and substance use 
disorder respectively that are not solely due to fixed factors. The equations defining this model were 
as follows: 
Model equations: 
 It = I + Ut  (t=1, 2, 3)  St = S + Wt  (t = 1, 2, 3) 
 U3 = B1 W3 + B3 U2 + 3 W3 = B2 U3 + B5 W2 + 3 
 U2 = B1 W2 + B4 U1 + 2 W2 = B2 U2 + B6 W1 + 2 
Model assumptions: 
 Cov(I, Ut) = Cov(I, Wt) = Cov(S, Ut) = Cov(S, Wt) = 0     (t = 1, 2, 3) 
 Cov(I, t) = Cov(I, t) = Cov(S, t) = Cov(S, t) = 0    (t = 2, 3) 
 Cov(t, s) = Cov(t, s) = Cov(t, s) = 0 for t  s  (t, s = 2, 3) 
 Cov(It, s) = Cov(It, s) = Cov(St, s) = Cov(St, s) = 0 for t < s 
 Cov(Ut, s) = Cov(Ut, s) = Cov(Wt, s) = Cov(Wt, s)  = 0 for t < s 
In these equations the terms t and t (t = 2, 3) represent disturbance terms reflecting unexplained 
sources of variation in the time-dynamic components of internalizing symptoms (Ut) and substance 
use disorder symptoms (Wt) respectively.  
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In the model, the coefficients B1, B2 represent the reciprocal effects of substance use 
disorder on internalizing disorder and vice versa respectively within each time period. The 
coefficients B3, B4 and B5, B6 represent the across time stabilities in the time-dynamic components 
of internalizing disorder and substance use disorder respectively. 
The model depicted in Figure 1 was fitted to the observed measures of internalizing disorder 
and substance use disorder at ages 18, 21, and 25 years. The fit of these models was then compared 
to the fit of two other models that assumed unidirectional causal effects between internalizing 
disorder and substance use disorder. These models were: (a) a model that assumed a unidirectional 
effect from substance use disorder to internalizing disorder (ie B1 ≠ 0; B2 = 0); and (b) a model that 
assumed a unidirectional effect from internalizing disorder to substance use disorder (ie B1 = 0; B2 
≠ 0). 
Since the observed measures were markedly non-normally distributed the models were fitted 
to the correlation matrix of the observed data using the method of weighted least squares. All 
models were fitted using LISREL 8 [42, 43]. Ascertainment of the best fitting model was 
undertaken via comparison of measures of model goodness of fit, including: (a) the model chi 
square goodness of fit statistic; (b) the Root Mean Squared Error of Approximation (RMSEA). 
Values of RMSEA less than .05 are assumed to be indicative of a well-fitting model; and (c) The 
Comparative Fit Index (CFI). This index varies between 0 and 1 with values close to 1 indicating a 
well fitting model [42]. 
To examine the sensitivity of the results to model estimation methods a series of alternative 
models was fitted to the data, which used symptom count measures of  depression and substance 
use disorder (and a count measure for anxiety disorders) in place of the ordered categorical 
measures described above. 
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Sample size and sample bias 
The present analyses are based on the sample of 953 participants for whom data on internalizing 
disorder and substance use disorder symptomatology were available on all assessments. This 
sample represented 75% of the initial cohort of 1265 participants.  
To adjust for possible sample selection bias resulting from sample attrition, a two-stage 
process was used. In the first instance, a sample selection model was constructed by using data 
gathered at birth to predict inclusion in the analysis sample. This showed that there were statistically 
significant (p<.05) tendencies for the obtained sample to under-represent children from more 
socially disadvantaged backgrounds (low parental education, low socio-economic status, single 
parent family). On the basis of the fitted selection models, the sample was then post-stratified into a 
series of groups and the probability of study participation estimated for each group.  
Then, analyses of the structural models were conducted that both (a) assumed missing 
observations within the analysis sample were missing at random and (b) weighted the observed data 
by the inverse of the probability of study participation. The analyses were conducted using WLS 
procedures that were robust to the data weighting and missing data assumptions.  In all cases the 
analyses produced essentially identical conclusions to the findings reported here, suggesting that the 
effects of missing data and selection bias on the results were likely to be minimal. 
 
Results 
Results of model fitting for internalizing disorder and substance use disorder 
Table 1 summarizes the findings of fitting the model depicted in Figure 1 to the data relating to the 
extent of: a) alcohol abuse/ dependence and depression; b) nicotine dependence and depression; c) 
illicit drug abuse/dependence and depression; d) alcohol abuse/ dependence and anxiety disorder; e) 
nicotine dependence and anxiety disorder; and f) illicit drug abuse/dependence and anxiety disorder.  
For each analysis the Table shows the best-fitting model as identified by three measures of 
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goodness of fit: the log likelihood ratio chi-square; the root mean square error of approximation 
(RMSEA), and the comparative fit index (CFI; see Methods).  The Table shows that: 
1) For models of the comorbidity between depression and substance use disorder, the best fitting 
model in all cases was a model assuming correlated fixed effects and a direct pathway between 
substance use disorders and depression. 
2) For models of the comorbidity between anxiety disorder and substance use disorder, two of the 
three best-fitting models assumed correlated fixed effects and a direct pathway between 
substance use disorder and anxiety disorder.  For anxiety disorder and alcohol 
abuse/dependence, the best fitting model was one assuming correlated fixed effects and 
reciprocal causal pathways between anxiety disorder and substance use disorder. 
In general, the results of the analyses show that, in most cases, the best-fitting models were those 
that included both fixed effects, and a direct causal path in which symptoms of substance use 
disorders led to increased symptoms of internalizing disorder.  For the comorbidity between alcohol 
abuse/dependence and anxiety disorder, there was also evidence of an additional reciprocal causal 
path in which increased symptoms of anxiety disorder led to increased symptoms of alcohol 
abuse/dependence. 
 
INSERT TABLE 1 HERE 
 
Decomposition of correlations between internalizing disorder and substance use disorder 
In order to examine the implications of the fitted models presented in Table 1, Table 2 shows: 
i. The observed product-moment correlations between each scale (internalizing disorder and 
substance use disorder) at each age of observation; 
ii. The components of the observed correlations that were explained by the correlated fixed effects 
component of the model; 
 12 
iii. The components of the correlations that were explained by the direct pathway between 
substance use disorder and internalizing disorder (or, in the case of anxiety disorder and alcohol 
abuse/dependence, the reciprocal pathways); 
iv. The unexplained portion of the correlations after fitting the models described in Table 1. 
The Table shows: 
1. For all analyses, a substantial portion of the correlation between internalizing disorder and 
substance use disorder was explained by the correlated fixed effects component of the models.  
These components of correlation ranged from .023 (anxiety disorder and illicit drug 
abuse/dependence) to .07 (depression and nicotine dependence).  Overall, the correlated fixed 
effects explained between 14.2% and 78.7% of the observed correlation (median value = 37.7). 
2. In addition, for all analyses, accounting for direct causal pathways between internalizing 
disorders and substance use disorder also accounted for a substantial portion of the correlations.  
These components of correlation ranged from .053 (anxiety disorder and nicotine dependence) 
to .145 (anxiety disorder and alcohol abuse/dependence).  Overall, the direct causal pathways 
between internalizing disorders and substance use disorders explained between 33.3% and 
100% of the observed correlation (median value = 64.5), suggesting that direct causal pathways 
accounted for a greater proportion of the correlations between internalizing disorders and 
substance use disorders than did correlated fixed effects. 
 
INSERT TABLE 2 HERE 
 
Sensitivity analyses 
As noted in Methods these results reported above were obtained from a WLS analysis fitted to an 
estimated matrix of Pearson correlations derived using ordered categorical measures of internalizing 
disorder and substance use disorder symptoms. To examine the sensitivity of the results to model 
estimation methods, alternative models were fitted to the data, using continuous count measures of 
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DSM-IV symptom criteria for internalizing disorder and substance use disorder (and in the case of 
anxiety disorder, a count measure of the number of anxiety disorders) in each year. In all cases, 
these models produced results consistent with those reported above, suggesting the following 
conclusions: 
1. The associations between substance use disorder and internalizing disorder were best explained 
by models that accounted for both correlated fixed effects and direct causal paths, in which 
increasing levels of substance use disorder symptoms lead to increased symptoms of 
internalizing disorder; for alcohol abuse/dependence and anxiety disorder, this causal path from 
substance use disorder to internalizing disorder was supplemented by a reciprocal causal path. 
2. The causal models of substance use disorder and internalizing disorder were found to be 




In this analysis we have used data gathered over the course of a longitudinal study to examine the 
comorbidities of internalizing disorders and substance use disorders. The analysis used advanced 
statistical modelling methods to control for fixed sources of confounding and to explore causal 
pathways. The analysis led to the following conclusions. 
 
Depression and substance use disorders 
In confirmation of previous research, the present data showed consistent comorbidity between 
depression and each of the three substance use disorders (alcohol abuse/dependence; nicotine 
dependence; illicit drug abuse/dependence) [5-9, 11-32, 34].  These correlations ranged from .08 to 
.17, with a median value of .14.  Structural equation models incorporating both correlated fixed 
factors and reciprocal causal pathways suggested that the best-fitting model was one in which 
increasing levels of substance use disorder symptoms led to increasing levels of depressive 
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symptomatology.  Decomposition of the correlations between substance use disorders and 
depression suggested that while correlated fixed effects accounted for a substantial portion of these 
comorbidities (31.7% to 78.7% of the correlations; median value = 42.9%) a rather larger portion 
was accounted for by direct causal pathways (33.3% to 82.7% of the correlations; median value = 
64.0%).  These results were consistent irrespective of whether the outcomes (depression and 
substance use disorders) were represented using an ordered categorical measure, or with measures 
of the total number of symptoms reported.  In general, these results are consistent with studies that 
have suggested that there is a causal relationship between substance use disorders and major 
depression, such that increasing levels of substance use disorder play a causal role in increasing 
risks of depression [8, 9, 16, 20, 22-25, 28, 31, 32]. 
 The findings of the present study, however, are not in agreement with a number of studies 
that have failed to find a persistent association between depression and substance use disorders [44-
48].  However, methodological differences may account for the discrepant findings; for example, 
several studies used sample selection methods that differed from the present study [44, 46], 
measured outcomes using retrospective recall [45, 47], or employed modelling techniques that 
differed from those in the present study [48].   
 
Anxiety disorders and substance use disorders 
As was the case with major depression, the present study demonstrated extensive comorbidity 
between anxiety disorders and substance use disorders, which is also generally consistent with a 
wide range of previous research [5-7, 10-12, 18, 21, 26, 30-32].   These correlations ranged from 
.10 to .19, with a median value of .13.   
 However, unlike the results for depression and substance use disorders, the structural models 
using reciprocal causal pathways produced somewhat less consistent results.  For both the 
comorbidity between nicotine dependence and anxiety disorder, and between illicit drug 
abuse/dependence and anxiety disorder, the results suggested, consistent with the findings for 
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depression and substance use disorders, that the data were best explained by a causal pathway in 
which increased levels of substance abuse/dependence led to increased levels of anxiety disorder 
symptomatology.  For alcohol abuse/dependence, the modelling of comorbidity suggested that the 
best-fitting model was one in which there were reciprocal causal pathways between alcohol 
abuse/dependence and anxiety disorder.  Decomposition of the correlations between substance use 
disorders and anxiety disorders suggested that while correlated fixed effects accounted for a 
substantial portion of these comorbidities (14.2% to 68.0% of the correlations; median value = 
34.4%) a rather larger portion was accounted for by direct causal pathways (45.7% to 100% of the 
correlations; median value = 73.3%).  In all cases, structural modelling using: a) symptom count 
measures for substance use disorders; and b) the total number of reported anxiety disorders; in place 
of the ordered categorical measures, produced similar results to the models using ordered 
categorical measures. 
 In general, the results of these analyses were consistent with a number of studies that have 
shown a persistent association between anxiety disorder and substance use disorder after controlling 
for confounding factors [10, 32, 33].  However, the findings of the present study were not in 
agreement with a number of studies that have failed to show associations between anxiety disorders 
and substance use disorders after control for common confounding [12, 31].  The reason for these 
discrepancies may be due to methodological differences between the present study and other 
studies; for example, one study compared depression, anxiety disorder, and behavioral disorder with 
comorbid disorders in terms of predicting concurrent substance abuse/dependence [12], while 
another study examined the first incidence of anxiety disorder [31]. 
 
Conclusions and limitations 
The general conclusions from the preceding analyses are that the associations between internalizing 
disorders and substance use disorders arise from two general pathways.  First, a substantial fraction 
of this correlation arises from a correlation between fixed factors associated with each outcome.  
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These factors may include common genetic and social factors associated with the development of 
substance use disorders and internalizing disorders [13, 20, 22, 44, 49-59].  Second, there were 
generally consistent findings of a direct causal pathway from substance use disorders to 
internalizing disorders.  These findings suggest that, independently of common fixed factors, the 
development of substance use disorders increased the likelihood of internalizing disorders.  There 
are two possible explanations of this causal link. 
 First, it may be suggested that the association between substance use disorder and 
internalizing disorder arises because of the effects of substance use on social, economic, and related 
circumstances which in turn increases risks of internalizing disorder.  These conclusions are 
consistent with a very large body of literature which suggests that substance use disorder is an 
important contributor to adverse life events involving health, economics, relationships, crime, and 
employment [60-62].  The alternative explanation is that the associations arise from underlying 
biological processes in which the use of substances leads to neurochemical changes that increase 
susceptibility to internalizing disorder [63-67].  Similarly, it could also be argued that the use of 
particular classes of substances may lead to changes in patterns of physiological arousal that 
increase susceptibility to internalizing disorder [68].   
Additionally, in contrast to a number of studies [13, 15, 17-21, 35, 36, 69], the results of the 
present study do not, in general, support “self-medication” theories of the origins of the comorbidity 
between substance use disorder and internalizing disorder.  In five of the six models, there was no 
evidence to suggest a pathway from internalizing disorder to substance use disorder; the only 
exception to these findings was the finding of a reciprocal causal pathway from anxiety disorders to 
alcohol abuse/dependence.  There may be several reasons why these findings may differ from the 
findings of previous studies that have found evidence for self-medication of internalizing disorders.  
For example, several other studies have used retrospective recall [13, 15, 21], while the present 
study was prospective in nature.  Also, a number of studies have not used structural equation 
modelling methods to examine assumptions regarding causal pathways [19, 20].  Furthermore, 
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some studies have found evidence for self-medication only amongst a subset of participants [17, 
36].  In addition, several studies did not model the associations between internalizing disorder and 
substance use disorder at multiple time periods [13, 15, 69]. 
Finally, it is important to recognise that the conclusions drawn in this analysis rely on some 
underlying assumptions that are necessary to identify the models we have presented. The most 
pervasive of these assumptions was that the pattern of comorbidity being studied was represented 
by a stable causal process that was operative throughout the course of this study. This is clearly a 
strong assumption, but it is essential for both the fixed effects and reciprocal causes models. Further 
research may be required to examine whether the assumptions regarding the stability of patterns of 
comorbidity between smoking and depression are correct.  Furthermore, it is likely that the models 
that we have used to represent these data are only approximations to a more complex set of 
conditions. For these reasons the findings of this study should be viewed as suggestive rather than 
definitive.   
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Figure 1.  Autoregressive model of internalizing disorder and substance use disorder symptomatology incorporating fixed effects and reciprocal paths between time dynamic 
components of internalizing and substance use disorder symptoms
Table 1. Description of best-fitting models 
 
Association Best-fitting Model Goodness of fit indices 
  Chi-square RMSEA CFI 
Depression - alcohol 
abuse/dependence 
Fixed effects + direct path from 
alcohol to depression 
χ2 (6) = 6.71 p = .35 .0100 .999 
Depression - nicotine 
dependence 
Fixed effects + direct path from 
nicotine to depression 
χ2 (6) = 10.87 p = .09 .0291 .996 
Depression - illicit drug 
abuse/dependence 
Fixed effects + direct path from 
illicit drugs to depression 
χ2 (6) = 10.85 p = .09 .0288 .994 
Anxiety - alcohol 
abuse/dependence 
Fixed effects + reciprocal 
causal pathwaysa 
χ2 (3) = 8.03 p = .04 .0413 .992 
Anxiety - nicotine 
dependence 
Fixed effects + direct path from 
nicotine to anxiety 
χ2 (6) = 10.94 p = .09 .0290 .996 
Anxiety - illicit drug 
abuse/dependence 
Fixed effects + direct path from 
illicit drugs to anxiety 
χ2 (6) = 5.34 p = .50 0.00 1.00 
 
a Of the array of models considered, this model was the best fitting, even though it failed to meet 
conventional criteria for good fit. 
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